Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Marriott

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Plos Neglected Tropical Diseases|August 4, 2025
Preclinical evaluation of the neutralising efficacy of three antivenoms against the venoms of the recently taxonomically partitioned E. ocellatus and E. romaniRebecca J Edge, Amy E Marriott, Molly Keen, et al.
Drugs & Aging|July 27, 2018
Invasive Candidiasis in the Elderly: Considerations for Drug TherapyB G J Dekkers, A Veringa, D J E Marriott, et al.
Internal Medicine Journal|January 3, 2013
Comparing dose prediction software used to manage gentamicin dosingC Wong, S S Kumar, G G Graham, et al.
Toxicon: X|March 24, 2022
<i>In vitro</i> and <i>in vivo</i> preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by <i>Dispholidus typus</i>Stefanie K Menzies, Rachel H Clare, Chunfang Xie, et al.
Antimicrobial Agents and Chemotherapy|December 28, 2020
Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill PatientsJ M Boonstra, A G Märtson, I Sandaradura, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2021
Reply to Van Daele et al., "Fluconazole Underexposure in Critically Ill Patients: a Matter of Using the Right Targets?"A-G Märtson, J M Boonstra, I Sandaradura, et al.
Toxicon: X|September 16, 2024
Plug and play virus-like particles for the generation of anti-toxin antibodiesRebecca J Edge, Amy E Marriott, Emma L Stars, et al.
Frontiers in Immunology|October 14, 2022
NKp46<sup>+</sup> natural killer cells develop an activated/memory-like phenotype and contribute to innate immunity against experimental filarial infectionNicolas Pionnier, Julio Furlong-Silva, Stefano A P Colombo, et al.
Internal Medicine Journal|December 9, 2014
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014M M Chau, D C M Kong, S J van Hal, et al.
British Journal of Clinical Pharmacology|July 21, 2021
Emerging therapeutic drug monitoring of anti-infective agents in Australian hospitals: Availability, performance and barriers to implementationIndy Sandaradura, Jan-Willem Alffenaar, Menino O Cotta, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Plos Neglected Tropical Diseases|August 4, 2025
Preclinical evaluation of the neutralising efficacy of three antivenoms against the venoms of the recently taxonomically partitioned E. ocellatus and E. romaniRebecca J Edge, Amy E Marriott, Molly Keen, et al.
Drugs & Aging|July 27, 2018
Invasive Candidiasis in the Elderly: Considerations for Drug TherapyB G J Dekkers, A Veringa, D J E Marriott, et al.
Internal Medicine Journal|January 3, 2013
Comparing dose prediction software used to manage gentamicin dosingC Wong, S S Kumar, G G Graham, et al.
Toxicon: X|March 24, 2022
<i>In vitro</i> and <i>in vivo</i> preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by <i>Dispholidus typus</i>Stefanie K Menzies, Rachel H Clare, Chunfang Xie, et al.
Antimicrobial Agents and Chemotherapy|December 28, 2020
Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill PatientsJ M Boonstra, A G Märtson, I Sandaradura, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2021
Reply to Van Daele et al., "Fluconazole Underexposure in Critically Ill Patients: a Matter of Using the Right Targets?"A-G Märtson, J M Boonstra, I Sandaradura, et al.
Toxicon: X|September 16, 2024
Plug and play virus-like particles for the generation of anti-toxin antibodiesRebecca J Edge, Amy E Marriott, Emma L Stars, et al.
Frontiers in Immunology|October 14, 2022
NKp46<sup>+</sup> natural killer cells develop an activated/memory-like phenotype and contribute to innate immunity against experimental filarial infectionNicolas Pionnier, Julio Furlong-Silva, Stefano A P Colombo, et al.
Internal Medicine Journal|December 9, 2014
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014M M Chau, D C M Kong, S J van Hal, et al.
British Journal of Clinical Pharmacology|July 21, 2021
Emerging therapeutic drug monitoring of anti-infective agents in Australian hospitals: Availability, performance and barriers to implementationIndy Sandaradura, Jan-Willem Alffenaar, Menino O Cotta, et al.
Pageof 10